Dutasteride and finasteride have similar risks of sexualdysfunction for treating androgenetic alopecia. Users experience varying side effects, indicating individual differences in drug reactions.
Finasteride is not linked to a 60% risk of persistent sexualdysfunction; this figure applies only to those already experiencing sexual issues. Most users do not have side effects, and the study's methodology is criticized for selection bias.
The conversation is about a finding that finasteride does not significantly increase the risk of sexualdysfunction, with users sharing mixed personal experiences regarding side effects.
Finasteride's potential side effects, especially sexualdysfunction, are discussed, with emphasis on hormonal balance between testosterone and estradiol. Users share experiences with finasteride, minoxidil, and dutasteride, highlighting the variability in side effects and the influence of mindset and lifestyle.